The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...

This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...

Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.

Despite recent evidence of its financial turnaround, Thermo Fisher’s layoff spree will continue into 2025. | Despite recent ...

Dr. Paulo H. Verardi, a virologist and head of the Department of Pathobiology and Veterinary Science at the University of ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

Researchers have demonstrated, for the first time in the world using mice, the ability to overcome significant challenges in ...

Dr. Montgomery Rice will be formally recognized at the Atlanta Business Chronicle's second annual Health Care Champion Awards ceremony on March 20, 2025.

Oxford, UK – 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint ...

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that ...

INFECTIOUS diseases are common among people living in unclean, polluted environment. Dirty environment is favourable for ...